Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB:ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C.
Related news for (ASAPF)
- Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
- Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
- Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
- Aurora Spine Corporation Announces Record First Quarter Financial Results
- Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results